Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa

  • By

  • Juling Sia

  • Bernett Lee

  • Hazel H. Oon

  • April 22, 2026

Share

  • 1

    Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder with significant comorbidities and impacts on quality of life.

  • 2

    Current HS treatments often fail, necessitating a combination of antibiotics, biologics, and sometimes surgical interventions.

  • 3

    The TL1A-DR3 signaling pathway is implicated in HS pathogenesis, influencing immune cell activity and fibrosis.

  • 4

    Anti-TL1A therapies, such as tulisokibart, are being evaluated for their efficacy in treating moderate-to-severe HS.

  • 5

    This review highlights the need for further research on the TL1A-DR3 axis and its role in HS to inform future clinical studies.

Original Source(s)

Exploring the Role of the TL1A-DR3 Pathway in Hidradenitis Suppurativa

  • by Juling Sia, Bernett Lee, Hazel H. Oon

  • April 22, 2026

Related Content

Top 10 Evidence-Based Essentials in Dermatology

A structured framework of guidelines, trials, therapies, and tools used in clinical practice

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

The Loan Cap That Could Shrink the Doctor Pipeline

New federal limits on medical school borrowing may quietly reshape who becomes a physician—and where they practice.